Motivational Interviewing for Vaccine Uptake in Latinx Adults
Launched by BOSTON COLLEGE · Sep 25, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Prior to the Coronavirus disease (COVID-19) pandemic, the World Health Organization declared vaccine hesitancy, defined as a delay in the acceptance or refusal of vaccination despite availability of vaccination services, as one of the top 10 threats to global health. Today, despite massive recent and ongoing global efforts, vaccine hesitancy remains a major threat, particularly in populations that experience health disparities rooted in structural racism. One such population is Hispanic/Latinx adults (Latinxs). Prior to the national COVID-19 vaccine campaign, Latinxs had twice the rate of C...
Gender
ALL
Eligibility criteria
- Patient Inclusion Criteria:
- • Aged 18 years and older
- • Identifies as Latinx
- • Completed an eligible behavioral health (BH) visit between the start and end dates of the intervention period.
- • Patient is missing a COVID-19 vaccine/booster or the influenza vaccine at the beginning of their behavioral health visit (i.e., they are not fully up to date with their COVID-19 and influenza vaccines)
- Patient Exclusion Criteria:
- • - NA
About Boston College
Boston College, a prestigious institution located in Chestnut Hill, Massachusetts, is committed to advancing research and education in the field of health sciences. As a clinical trial sponsor, Boston College leverages its robust academic resources and interdisciplinary expertise to facilitate innovative research initiatives aimed at improving patient outcomes. The institution fosters collaboration among faculty, students, and healthcare professionals, ensuring that clinical trials conducted under its auspices are grounded in rigorous scientific methodology and ethical considerations. With a focus on translating research findings into real-world applications, Boston College plays a pivotal role in contributing to the broader medical community and enhancing the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Patients applied
Trial Officials
Kirsten Davison, PhD
Principal Investigator
Boston College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported